Company Monitoring Page for Zafgen

latest headlines for company on cafepharma

Zafgen Finally Speaks About Stock Plunge, But Says Nothing
TheStreet.com
Wed, 10/14/15 - 09:56 am
Tags:
Zafgen
Zafgen Cancels Meetings, Investors Fear the Worst
TheStreet.com
Mon, 10/12/15 - 04:30 pm
Tags:
Zafgen
Biogen And Four Other Biotech Stocks Worth Watching
Forbes
Sat, 10/10/15 - 09:12 am
Tags:
Biogen, Esperion, Zafgen, Clovis Oncology, Portola
Zafgen Completes Enrollment of Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes
Yahoo
Wed, 09/9/15 - 08:05 am
Tags:
Zafgen, beloranib, clinical trials, obesity, diabetes
Zafgen Announces New Weight Loss and Safety Data from Phase 2 Trial of Beloranib in Hypothalamic Injury Associated Obesity at ENDO 2015
Yahoo
Sun, 03/8/15 - 10:18 am
Tags:
Zafgen, hypothalamic injury-associated obesity, beloranib
Booming biotechs bank $2.7B in follow-on cash
Fierce Biotech
Fri, 01/23/15 - 03:38 pm
Tags:
biotech, Prosensa, Biomarin, Zafgen, Alnylam, Auspex, Puma Biotechnology, Arena Pharmaceuticals, Radius Health, Intrexon
Zafgen's promising obesity drug comes through in another midstage trial
Fierce Biotech
Wed, 01/7/15 - 09:23 am
Tags:
Zafgen, obesity, beloranib, hypothalamic injury-associated obesity
2014's most successful biotech IPOs
Fierce Biotech
Mon, 10/13/14 - 08:03 am
Tags:
IPOs, biotech, Ultragenyx, ZS Pharma, Auspex Pharmaceuticals, Avalanche Biotechnologies, SAGE Therapeutics, Kite Pharma, Otonomy, Zafgen, ProQR, Radius Health
You’ve got obesity all wrong: Zafgen CEO
CNBC
Tue, 08/19/14 - 01:44 pm
Tags:
obesity, Zafgen, Pharma CEOs, beloranib
Framing Up Capital Efficiency In Early Stage Biotech
Forbes
Thu, 07/17/14 - 09:18 am
Tags:
biotech, capital efficiency, Zafgen, IPOs, Agios
Zafgen Supersizes Its Obesity-Focused IPO: An Early Investor's Reflections
Forbes
Wed, 06/25/14 - 07:44 am
Tags:
Zafgen, obesity, IPOs
The Future of Fat Fighting: Next-Gen Obesity Drugs
Motley Fool
Sun, 05/25/14 - 10:30 am
Tags:
obesity, weight loss, Zafgen, beloranid, Arena, Vivus, Qsymia, Belviq
Zafgen Opens A New Front In Its Obesity Strategy: Prader-Willi Syndrome
Forbes
Thu, 01/16/14 - 09:27 am
Tags:
obesity, Zafgen, Prader-Willi Syndrome, beloranib
The Weight Loss Drug Company Investors Need to Watch Out For
Motley Fool
Fri, 12/13/13 - 08:32 am
Tags:
beloranib, Zafgen, Vivus, Arena Pharmaceuticals
Zafgen drug helps patients lose up to 24 pounds
Yahoo/Reuters
Fri, 11/15/13 - 08:42 am
Tags:
Zafgen, beloranib, obesity
New entrant in obesity drug race targets body, not the mind
Reuters
Sat, 08/24/13 - 11:35 am
Tags:
Zafgen, obesity, weight loss. Beloranib
Zafgen Says Obesity Drug Spurs Weight Loss in Study
Bloomberg
Sun, 06/23/13 - 11:07 am
Tags:
Zafgen, obesity, weight loss, beloranib
And the Obesity Plot Thickens
Motley Fool
Wed, 01/2/13 - 11:58 am
Tags:
obesity, Vivus, Arena Pharmaceuticals, Roche, Orexigen, mimAb1, Amgen, Zafgen, Belviq, Qsymia, beloranib, Contrave
Obesity Drugs Gain Attention on FDA Backing for Therapies
Bloomberg
Wed, 09/19/12 - 10:53 am
Tags:
FDA, obesity, Zafgen, beloranib, Arena Pharmaceuticals
Zafgen Announces Cardiovascular Data from Phase 1b Study of ZGN-433 in Obesity at American Diabetes Association Annual Meeting
Enhanced Online News
Sat, 06/25/11 - 11:25 am
Tags:
Zafgen, ZGN-433, obesity, weight loss

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.